Alchemy, a San Francisco, CA-based company implementing clinical pharmacy programs, raised $31M in Seed funding.
The round was led by Andreessen Horowitz (“a16z”) Bio + Health with participation from Earvin “Magic” Johnson, Sandberg Bernthal Venture Partners, Banc of California and existing investors Twine Ventures, Springbank and AlleyCorp.
The company intends to use the funds to accelerate growth and launch in-house pharmacy programs across 20 states over the next year. Alchemy will also expand its offerings to include a mobile clinic program and a digital platform to streamline pharmacy operations and patient communication.
Alchemy provides the entire physical, clinical, and digital infrastructure needed to build, operate and grow in-house pharmacy programs with a focus on serving clinics with large HIV and Hepatitis C (HCV) patient populations. After setting up an in-house pharmacy, the company designs and implements clinical pharmacy programs and deploys technology products that leverage the pharmacy to expand patient reach, improve health outcomes, and increase the financial impact of a clinic’s pharmacy program.
FinSMEs
15/10/2024